Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7275 EUR -1.09%
Market Cap: 493.5m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Pharming Group NV
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharming Group NV
Net Income Peer Comparison

Comparables:
PRQR
QURE
ARGX
MRUS
LVTX

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Pharming Group NV
AEX:PHARM
Net Income
-$17.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ProQR Therapeutics NV
NASDAQ:PRQR
Net Income
-€21.3m
CAGR 3-Years
27%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Net Income
-$239.5m
CAGR 3-Years
N/A
CAGR 5-Years
-18%
CAGR 10-Years
-18%
argenx SE
XBRU:ARGX
Net Income
-$358.1m
CAGR 3-Years
-31%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Net Income
-$244.6m
CAGR 3-Years
-45%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Net Income
-$41.7m
CAGR 3-Years
-39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharming Group NV's Net Income?
Net Income
-17.2m USD

Based on the financial report for Sep 30, 2024, Pharming Group NV's Net Income amounts to -17.2m USD.

What is Pharming Group NV's Net Income growth rate?
Net Income CAGR 1Y
39%

Over the last year, the Net Income growth was 39%.

Back to Top